Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IHE vs. PRHSX: which is better?

Bottom line

IHE vs PRHSX: the short answer

IHE (iShares U.S. Pharmaceuticals ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 40% by weight.

But PRHSX is far broader, holding 279 positions to 59 for IHE, so beyond the top names it adds exposure IHE doesn't have.

IHE is cheaper at 0.37% vs 0.83% — a difference of $46 a year per $10,000 invested.

Over five years, IHE returned +9.1% a year vs +4.2% for PRHSX.

Updated Nov 19, 2026

IHE vs PRHSX side by side

IHEPRHSX
TypeETFMutual fund
Fund familyiSharesT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.37%0.83%
Annual cost per $10k$37$83
10-yr cost on $10k (prospectus)$468$1,025
Max front loadNone—
12b-1 fee0%—
1-yr return+31.7%+17.7%
5-yr return (annualized)+9.1%+4.2%
10-yr return (annualized)+6.2%+9.1%
Best quarter+17.6%+23.5%
Worst quarter−16.0%−15.8%
Net assets (fund)$1.1B$11.9B
Number of holdings59279
Portfolio turnover29%62%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIHEPRHSXDifference
2025+31.7%+17.7%+14.0%
2024+8.1%+1.8%+6.3%
2023+1.0%+3.1%−2.1%
2022−4.8%−12.2%+7.4%
2021+12.8%+13.3%−0.4%
2020+13.8%+30.1%−16.3%
2019+15.5%+29.1%−13.6%
2018−7.7%+1.2%−8.9%
2017+10.7%+28.0%−17.3%
2016−11.7%−10.4%−1.4%

Source: Fund prospectus bar charts

Holdings overlap

4 of IHE's top 25 holdings also appear in PRHSX's top 25.

Shared top holdings
HoldingIHEPRHSX
Johnson & Johnson22.44%6.63%
Eli Lilly And Company22.25%14.28%
Merck & Co., Inc.4.55%4.01%
Bristol-myers Squibb Company4.37%2.11%

Source: SEC Form N-PORT

IHE top 10

  1. Johnson & Johnson — 22.44%
  2. Eli Lilly And Company — 22.25%
  3. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  4. Merck & Co., Inc. — 4.55%
  5. Bristol-myers Squibb Company — 4.37%
  6. Royalty Pharma Plc — 4.34%
  7. Viatris Inc. — 4.22%
  8. Pfizer Inc. — 3.96%
  9. Zoetis Inc. — 3.73%
  10. Jazz Pharmaceuticals Public Limited Company — 3.45%

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FAQ

What is the difference between IHE and PRHSX?
IHE (iShares U.S. Pharmaceuticals ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 40% by weight. But PRHSX is far broader, holding 279 positions to 59 for IHE, so beyond the top names it adds exposure IHE doesn't have.
Which is cheaper, IHE or PRHSX?
IHE has the lower expense ratio (0.37%).
Should I own both IHE and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.